Beth Isreal Deaconess Medical Center is a clinical research site located in Boston, Massachusetts, United States 02215.
Crixeo Health Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.
Beth Isreal Deaconess Medical Center has participated in 25 clinical trials with 5 currently active.
Therapeutic areas: Peripheral Arterial Disease, Symptomatic Femoropopliteal Lesions, Chronic Lymphocytic Leukemia.
Sponsors: Endologix, Dana-Farber Cancer Institute, Joslin Diabetes Center.
Trust Score: 84/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Beth Isreal Deaconess Medical Center has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Beth Isreal Deaconess Medical Center has 25 clinical trials on record, with 5 currently active. Their work covers Peripheral Arterial Disease, Symptomatic Femoropopliteal Lesions, Chronic Lymphocytic Leukemia.
Yes — Beth Isreal Deaconess Medical Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.